POSTER SESSION IV
Tuesday, March 1, 2011 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Metaplastic Breast Carcinomas Are Enriched for ALDH-1 Positive Stem Cells in Non-Glandular Elements.
(294)
Y Zhang, K Toy, CG Kleer - University of Michigan, Ann Arbor
Histological Characterization of Carcinoma In Situ and Benign Lesions Associated with Metaplastic Carcinoma of the Breast.
(244)
A Rodrigues, C Leal - Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE, Porto, Portugal
Immunostains Laminin-5 γ2, Kalinin B1 and αβ-Crystallin in the Evaluation of Malignant Spindle Cell Tumors of the Breast.
(246)
DS Ross, TM D'Alfonso, Y-F Liu, S Monni, SJ Shin - Weill Cornell Medical College, New York
Expression of the Cancer Stem Cell Marker ALDH1 in Triple Negative Breast Cancer: Prognostic Impact and Tumor Microenvironment.
(141)
M De Brot, RM Rocha, FA Soares, H Gobbi - Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Hospital A.C. Camargo, Sao Paulo, Brazil
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase-1A1 Expression with Poor Prognosis in the Conventional Cytotoxic Neoadjuvant Chemotherapy.
(193)
T Khoury, A Foluso, R Chandraseekhar, W Gregory, AB DeLeo, S Ferrone, Y Wang, L Monhollen, D Tan, X Wang - Roswell Park Cancer Institute, Buffalo; University of Pittsburgh Medical Center, PA; MD-Anderson Cancer Center, Houston
Stem Cell Marker (ALDH1) Is a Strong Prognostic Factor in Breast Cancer.
(235)
A Plotkin, S Nofech-Mozes, SA Narod, P Sun, E Rawlinson, WM Hanna - University of Toronto, ON, Canada
Different Patterns of Stem Cell-Related Markers Expression between Luminal B and Invasive Micropapillary Carcinoma of the Breast.
(162)
N Gruel, A Cedenot, M Richardson, P Freneaux, F Reyal, A Fourquet, P Cottu, X Sastre-Garau, T Dubois, O Delattre, A Vincent-Salomon - Institut Curie, Paris, France
Expression of Two Stem Cell Markers (ALDH1 and Notch1) in Inflammatory Breast Carcinoma.
(279)
JF Wang, P Liu, Y Gong - The University of Texas MD Anderson Cancer Center, Houston
Comparing the Intrinsic Tumor Subtype of Invasive and In-Situ Components of Breast Carcinoma: Analysis of 34 Tumors Using the PAM50 RT-PCR Assay.
(101)
N Banet, CM Perou, KA Hoadley, PS Bernard, C Livasy - University of North Carolina, Chapel Hill; Carolinas Medical Center, Charlotte, NC; University of Utah, Salt Lake City
Genomic Analysis of Matched In Situ to Invasive Ductal Carcinomas Provides Direct Evidence for Selection of Invasive Cancer Cells with Specific Genetic Aberrations.
(165)
L Hernandez, MB Lambros, C Cabral, R Vatcheva, A Mackay, P Wilkerson, R Natrajan, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom
Etanercept as a New Agent for the Treatment of ErbB-2 Overexpressing Breast Tumors.
(243)
MA Rivas, M Tkach, E Maronna, R Sanchez Marull, W Beguelin, CJ Proietti, MC Diaz Flaque, EH Charreau, PV Elizalde, R Schillaci, I Frahm - Instituto de Biologia y Medicina Experimental-CONICET, Buenos Aires, Argentina; Sanatorio Mater Dei, Buenos Aires, Argentina
The Breast Cancer-Body Fat Enigma: Paradoxical Changes in Fat and Serum Biomarkers in Response to Fatty Acid Intake.
(163)
RW Hardy, M-C Shen, LM Evans, EC Toline, RA Desmond, GP Siegal - University of Alabama at Birmingham
p27 and Ki-67 in Invasive Breast Carcinoma with Unamplified Chromosome 17 Polysomy.
(293)
O Yergiyev, JF Silverman, U Krishnamurti - Allegheny General Hospital, Pittsburgh, PA; Western Pennsylvania Hospital, Pittsburgh
Down-Regulation of Proliferation and Cell Adhesion and Up-Regulation of Cell Migration Associated Genes in Lobular Breast Carcinomas.
(118)
B Castellana, E Lerma, E Serrano, G Peiro, D Escuin, A Tibau, C Pons, M Perez, A Barnadas - Hospital de la Santa Creu i Sant Pau. Universitat Autonoma, Barcelona, Spain; Hospital de Alicante, Spain
ASPN, GJB2, ENPP2, ST6GAL2 and TMSB10 Are Related with Invasiveness in Ductal Breast Carcinomas.
(117)
B Castellana, E Serrano, G Peiro, B Ojeda, C Alonso, T Vazquez, J Munoz, A Barnadas, E Lerma - Hospital de la Santa Creu i Sant Pau. Universitat Autonoma, Barcelona, Spain; Hospital de Alicante, Spain
Genomic Profiling of Adenoid Cystic Carcinomas of the Breast.
(205)
M-A Lopez-Garcia, D Wetterskog, MB Lambros, FC Geyer, R Vatcheva, Z Gatalica, B Weigelt, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom; Hospital Universitario Virgen del Rocio, Seville, Spain; Creighton University Medical Center, Omaha; CRUK London Research Institute, United Kingdom
Absence of Microsatellite Instability in Mucinous Carcinomas of the Breast.
(197)
M Lacroix-Triki, MB Lambros, FC Geyer, PH Suarez, JS Reis-Filho, B Weigelt - Institute of Cancer Research, London, United Kingdom; Institut Claudius Regaud, Toulouse, France; Cancer Research UK, London Research Institute, United Kingdom
MYB-NFIB Gene Fusion: A Characteristic Feature of Adenoid Cystic Carcinoma of the Breast.
(286)
D Wetterskog, M-A Lopez-Garcia, MB Lambros, FC Geyer, C Cabral, R Vatcheva, K Savage, B Weigelt, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom; Hospital Universitario Virgen del Rocio, Seville, Spain; Cancer Research UK, London Research Institute, United Kingdom
Identification of Drivers of the 11q13 Amplicon.
(288)
P Wilkerson, A Mackay, MB Lambros, R Natrajan, H Horlings, MJ van de Vijver, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom; Academic Medical Center, Amsterdam, Netherlands
Functional Characterisation of the 19q12 Amplicon in Grade 3 Breast Cancers.
(223)
R Natrajan, D Wetterskog, MB Lambros, FC Geyer, A Mackay, R Vatcheva, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom
The Role of Type XI and Type XVII Collagen in Breast Cancer Progression.
(270)
AC Vargas, P Simpson, L Annette, S Chanel, A Reed, DS Leonard, L Sunil - UQ Centre for Clinical Research, Brisbane, Australia
Characterization of Androgen Receptor in Breast Cancer Tissue.
(275)
A Vora, E Siegel, L Hennings, L Talley, S Korourian - University of Arkansas for Medical Sciences, Little Rock
Cyclin D1 and CYCLIN E Expression Analysis in Pakistani Breast Tumors Linked with BRCA1 Mutations.
(207)
A Loya, MU Rashid, D Torres, M Tehseen, S Bajwa, A Amin, U Hamann - Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany; Instituto de Genetica Humana, Pontificia Universidad Javeriana, Bogota, Colombia; Blumenthal Cancer Center, Carolinas Medical Center, Charlotte, NC
Tubular Breast Carcinoma: Critical Evaluation of ER/PR Expression and Gene Expression Profile.
(182)
J Jorns, D Visscher, D Thomas, P Healy, S Daignault-Newton - University of Michigan, Ann Arbor
Invasive Mucinous Breast Carcinomas Lack PIK3CA/AKT Pathway Mutations.
(191)
E Kehr, A Warrick, T Neff, R Lewis, M Degnin, C Beadling, C Corless, M Troxell - OHSU, Portland, OR
A Complex Genetic Basis for Breast Cancer Subtypes.
(262)
TP Stricker, CD Brown, V Montoya, M McNerney, R Kittler, S Karmakar, RL Grossman, KP White - University of Chicago, IL; University of. Illinois at Chicago
Using the Signature Phenotype of Inflammatory Breast Cancer To Study Dormancy and Resistance to Therapeutics.
(134)
AD Corben, C D'Arcy, S Modi, G Chiosis, ML Alpaugh - Memorial Sloan-Kettering Cancer Center, New York, NY
Molecular Subtype of Breast Carcinoma: Comparison of the Incidence, Locoregional Recurrence and Distant Metastasis between African American and Caucasian Women.
(181)
DL Johnson, HT Richard, CN Powers, MO Idowu - Virginia Commonwealth University, Richmond
Evaluation of Raf-1 Kinase Inhibitor Protein in Breast Carcinoma and Its Potential Significance.
(295)
PJ Zhang, J Culin, P Lal, G Acs - Hospital of the University of Pennsylvania, Philadelphia; Moffitt Cancer Center, Tampa, FL
WWOX Gene Methylation, WWOX and FHIT Protein Expression in Primary Breast Tumors and Breast Parenchymal Tissues and Their Relationship to Prognostic and Epidemiological Data.
(167)
C Himmetoglu Ussakli, K Huebner, G Guler - Hacettepe University Faculty of Medicine, Ankara, Turkey; The Ohio State University Medical Center, Columbus
Lack of the Tailored Use of Anthracycline in the Lobular Subtype of Breast Carcinoma: Evidence on the Topoisomerase-IIa Amplicon.
(113)
E Brunello, M Brunelli, E Manfrin, A Nottegar, S Bersani, M Vergine, M Chilosi, G Martignoni, F Bonetti - University of Verona, Italy
button next to any title to add to Itinerary Planner...
Add
